Search research articles
Contact Us
Filters
Showing results (31-40 of 105) with videos related to
Page
of 11
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 22, 2022
Alcohol-Associated Liver Disease Mortality Increased From 2017 to 2020 and Accelerated During the COVID-19 Pandemic
Sasha Deutsch-Link, Yue Jiang, Anne F Peery, et al.
Hepatology Communications
|
September 12, 2021
Alcohol-Associated Liver Disease Before and After COVID-19-An Overview and Call for Ongoing Investigation
Andrew M Moon, Brenda Curtis, Pranoti Mandrekar, et al.
Clinical Transplantation
|
February 9, 2022
Changing opportunities for liver transplant for patients with hepatocellular carcinoma
Alex Zendel, Randall Watkins, Andrew M Moon, et al.
Alimentary Pharmacology & Therapeutics
|
March 13, 2020
Letter: are opioid prescriptions associated with hepatic encephalopathy in patients with compensated cirrhosis? Authors' reply
Andrew M Moon, Yue Jiang, Shari S Rogal, et al.
Alimentary Pharmacology & Therapeutics
|
January 22, 2020
Opioid prescriptions are associated with hepatic encephalopathy in a national cohort of patients with compensated cirrhosis
Andrew M Moon, Yue Jiang, Shari S Rogal, et al.
Nature Reviews. Gastroenterology & Hepatology
|
March 11, 2021
COVID-19 and liver disease: mechanistic and clinical perspectives
Thomas Marjot, Gwilym J Webb, Alfred S Barritt, et al.
The American Journal of Gastroenterology
|
December 17, 2025
Enhancing Patient Empowerment through Artificial Intelligence in Liver Cancer
Dee Lee, Zorana Maravic, Andrew M Moon, et al.
Digestive Diseases and Sciences
|
July 13, 2020
Nonalcoholic Fatty Liver Disease Risk Factors Affect Liver-Related Outcomes After Direct-Acting Antiviral Treatment for Hepatitis C
Jihane N Benhammou, Andrew M Moon, Joseph R Pisegna, et al.
The American Journal of Gastroenterology
|
February 2, 2023
Systematic Review and Meta-Analysis on the Effects of Lactulose and Rifaximin on Patient-Reported Outcomes in Hepatic Encephalopathy
Andrew M Moon, Hannah P Kim, Yue Jiang, et al.
Alimentary Pharmacology & Therapeutics
|
November 13, 2023
Hepatocellular carcinoma risk decreases as time accrues following hepatitis C virus eradication
Philip Vutien, Nicole J Kim, Andrew M Moon, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 105) with videos related to
Sort By:
Page
of 11
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 22, 2022
Alcohol-Associated Liver Disease Mortality Increased From 2017 to 2020 and Accelerated During the COVID-19 Pandemic
Sasha Deutsch-Link, Yue Jiang, Anne F Peery, et al.
Hepatology Communications
|
September 12, 2021
Alcohol-Associated Liver Disease Before and After COVID-19-An Overview and Call for Ongoing Investigation
Andrew M Moon, Brenda Curtis, Pranoti Mandrekar, et al.
Clinical Transplantation
|
February 9, 2022
Changing opportunities for liver transplant for patients with hepatocellular carcinoma
Alex Zendel, Randall Watkins, Andrew M Moon, et al.
Alimentary Pharmacology & Therapeutics
|
March 13, 2020
Letter: are opioid prescriptions associated with hepatic encephalopathy in patients with compensated cirrhosis? Authors' reply
Andrew M Moon, Yue Jiang, Shari S Rogal, et al.
Alimentary Pharmacology & Therapeutics
|
January 22, 2020
Opioid prescriptions are associated with hepatic encephalopathy in a national cohort of patients with compensated cirrhosis
Andrew M Moon, Yue Jiang, Shari S Rogal, et al.
Nature Reviews. Gastroenterology & Hepatology
|
March 11, 2021
COVID-19 and liver disease: mechanistic and clinical perspectives
Thomas Marjot, Gwilym J Webb, Alfred S Barritt, et al.
The American Journal of Gastroenterology
|
December 17, 2025
Enhancing Patient Empowerment through Artificial Intelligence in Liver Cancer
Dee Lee, Zorana Maravic, Andrew M Moon, et al.
Digestive Diseases and Sciences
|
July 13, 2020
Nonalcoholic Fatty Liver Disease Risk Factors Affect Liver-Related Outcomes After Direct-Acting Antiviral Treatment for Hepatitis C
Jihane N Benhammou, Andrew M Moon, Joseph R Pisegna, et al.
The American Journal of Gastroenterology
|
February 2, 2023
Systematic Review and Meta-Analysis on the Effects of Lactulose and Rifaximin on Patient-Reported Outcomes in Hepatic Encephalopathy
Andrew M Moon, Hannah P Kim, Yue Jiang, et al.
Alimentary Pharmacology & Therapeutics
|
November 13, 2023
Hepatocellular carcinoma risk decreases as time accrues following hepatitis C virus eradication
Philip Vutien, Nicole J Kim, Andrew M Moon, et al.
Page
of 11